Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VHT vs TMED overlap: 48% of top holdings shared

Bottom line

How much do VHT and TMED overlap?

48% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 35.5% of VHT's assets and 45.5% of TMED's. They share a meaningful core but differ in the rest of the portfolio.

VHT holds far more positions (407 vs 102), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

VHTTMED
Weight overlap (top 25)48%
Shared holdings10
Weight in shared holdings35.5%45.5%
Total positions407102
Expense ratio0.09%0.44%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings VHT and TMED have in common

Holding% of VHT% of TMEDOverlap
Eli Lilly & Co14.04%16.71%14.04%
UnitedHealth Group Inc5.45%6.52%5.45%
Thermo Fisher Scientific Inc2.93%4.11%2.93%
Gilead Sciences Inc2.64%4.44%2.64%
Intuitive Surgical Inc2.38%2.43%2.38%
Pfizer Inc2.35%1.91%1.91%
Danaher Corp1.84%2.96%1.84%
Stryker Corp1.66%2.22%1.66%
McKesson Corp1.45%1.46%1.45%
Cencora Inc0.79%2.75%0.79%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VHT

  1. Johnson & Johnson — 8.47%
  2. AbbVie Inc — 6.09%
  3. Merck & Co Inc — 4.66%
  4. Amgen Inc — 2.87%
  5. Abbott Laboratories — 2.35%
  6. Bristol-Myers Squibb Co — 1.84%
  7. CVS Health Corp — 1.83%
  8. Vertex Pharmaceuticals Inc — 1.80%
  9. Medtronic PLC — 1.50%
  10. Elevance Health Inc — 1.35%
  11. Cigna Group/The — 1.17%
  12. Boston Scientific Corp — 1.13%
  13. Regeneron Pharmaceuticals Inc — 1.00%
  14. HCA Healthcare Inc — 0.96%
  15. Edwards Lifesciences Corp — 0.79%

Only in TMED

  1. Agilent Technologies Inc — 2.61%
  2. Alnylam Pharmaceuticals Inc — 2.60%
  3. Insulet Corp — 2.38%
  4. Dyne Therapeutics Inc — 2.03%
  5. Elanco Animal Health Inc — 1.91%
  6. Cytokinetics Inc — 1.69%
  7. Waters Corp — 1.68%
  8. West Pharmaceutical Services — 1.65%
  9. Ascendis Pharma A/s — 1.60%
  10. Biogen Inc — 1.55%
  11. Dexcom Inc — 1.46%
  12. Immunome Inc — 1.38%
  13. Biontech Se-adr — 1.29%
  14. Humana Inc — 1.24%
  15. Denali Therapeutics Inc — 1.22%

Asset mix

Asset typeVHTTMED
Stocks99.8%99.3%
Cash & short-term funds0.2%0.7%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryVHTTMED
US100.0%93.3%
DK—1.6%
DE—1.6%
KY—1.1%
NL—0.9%
CH—0.5%
CA—0.3%
JE—0.3%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do VHT and TMED overlap?
About 48% by weight. 10 securities appear in both funds' top 25 holdings; they make up 35.5% of VHT's assets and 45.5% of TMED's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VHT and TMED have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Gilead Sciences Inc, Intuitive Surgical Inc.
Should I own both VHT and TMED?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VHT or TMED?
VHT is broader, with 407 positions versus 102 for TMED. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.